Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.

J, Yang; WM, Bahk; HS, Cho; YW, Jeon; DI, Jon; HY, Jung; CH, Kim; HC, Kim; YK, Kim; YH, Kim; JS, Kwon; SY, Lee; SH, Lee; JS, Yi; BH, Yoon; SH, Kim

doi:10.1097/wnf.0b013e3181dcda50

Public

Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.

Shared by NobleBlocks on Jul 1, 2010 • 12:00 AM UTC

Authors:

Yang J

Bahk WM

Cho HS

Abstract

Objectives The objective of this study was to evaluate the efficacy and tolerability of blonanserin for the treatment of Korean patients with schizophrenia using a double-blind risperidone-compared design.Methods Patients aged 18 to 65 years with schizophrenia were randomly assigned to blonanserin o...

Discussions